Omeza Receives FDA Clearance for Omeza® Collagen Matrix
Omeza announced today the U.S. Food and Drug Administration (FDA) cleared Omeza® Collagen Matrix through the FDA 510(k) premarket notification process. Omeza® Collagen Matrix is Omeza’s first Rx product, and the first drug/device combination matrix of its kind for chronic wound care.